Karas Eric Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$560,423.37

Insider Activity of Karas Eric

According to the SEC Form 4 filings, Karas Eric, being in a position of

  1. Chief Commercial Officer at ARS Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25000 shares for $250,000,
    over all time since 2024-08-19, has bought 0 shares, and sold 95000 shares for $1.31M.

Biography of Karas Eric

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $250,0001100

Comparison of Insiders on Amount of Buys and Sells

2026-06-12SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
25,000
0.0263%
$10.00$250,000-42.42%
2025-07-01SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
15,000
0.0161%
$16.99$254,861-39.59%
2025-06-18SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
15,000
0.0154%
$16.00$240,000-38.47%
2025-03-20SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
10,000
0.0101%
$14.00$140,000-21.59%
2024-12-04SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
6,283
0.0063%
$14.00$87,962-13.28%
2024-12-02SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
3,717
0.0041%
$14.11$52,461-5.78%
2024-09-18SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
10,000
0.0099%
$14.00$140,000-0.36%
2024-08-19SaleARS Pharmaceuticals, Inc.
SPRY
Chief Commercial Officer
10,000
0.0099%
$14.00$140,000-1.69%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.